Overview of Dr. Barbieri
Dr. Christopher Barbieri is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 10 years. He is one of 189 doctors at New York-Presbyterian Hospital and one of 62 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Urology. He has more than 100 publications and over 500 citings.
Office
535 E 68th St
New York, NY 10065
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2009 - 2013- New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2007 - 2009
Vanderbilt University School of MedicineClass of 2007
Certifications & Licensure
NY State Medical License 2009 - 2026- American Board of Urology Urology
Awards, Honors, & Recognition
- MetLife Clinical Investigator Award Damon Runyon Cancer Research Foundation, 2016
- Rising Star in Urology Research Urology Care Foundation / AUA, 2015
- Challenge Award Prostate Cancer Foundation, 2014
- Join now to see all
Publications & Presentations
PubMed
- Clonal Lineage Tracing with Somatic Delivery of Recordable Barcodes Reveals Migration Histories of Metastatic Prostate Cancer.Ryan N Serio, Armin Scheben, Billy Lu, Domenic V Gargiulo, Lucrezia Patruno
Cancer Discovery. 2024-10-04 - Trends in Active Surveillance for Men With Intermediate-Risk Prostate Cancer.Marshall A Diven, Lhaden Tshering, Xiaoyue Ma, Jim C Hu, Christopher Barbieri
JAMA Network Open. 2024-08-01 - USP11 promotes prostate cancer progression by up-regulating AR and c-Myc activity.Majid Pornour, Hee-Young Jeon, Hyunju Ryu, Sudeep Khadka, Rui Xu
Proceedings of the National Academy of Sciences of the United States of America. 2024-07-30
Journal Articles
- Impact of Pelvic Radiation Therapy on Inflatable Penile Prosthesis Reoperation RatesChristopher E Barbieri, James A Kashanian, The Journal of Sexual Medicine
- Introduction to “Molecular Drivers of Prostate Cancer Development, Progression, and Resistance to Therapy”Christopher Barbieri, MD, Urologic Oncology
- Molecular Subtypes of Prostate CancerChristopher Barbieri, MD, Current Oncology Reports
Authored Content
- SPOP Mutated/ CHD1 Deleted Lethal Prostate Cancer and Abiraterone SensitivityMarch 2018
Press Mentions
Putting the Brakes on Prostate Cancer CellsDecember 13th, 2024- What You Need to Know About Prostate Cancer TreatmentsOctober 7th, 2024
- Prostate Cancer’s Spread Modeled with CRISPR Barcoding TechnologySeptember 23rd, 2024
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
